6 Multibagger Stocks That Surged After FIIs Corrected Their Mistakes

While Foreign Institutional Investors (FIIs) have largely acted as bears on Dalal Street, a closer look at the data reveals a different story of selective conviction. In several high-growth stocks, FIIs executed a dramatic "U-turn," reversing their selling streaks to accumulate positions that have since delivered massive multibagger returns.

The Great FII Reversal: From Selling to Accumulating

Data from ACE Equity highlights a fascinating pattern: six specific stocks saw FIIs aggressively raise their stakes in the March quarter after two consecutive quarters of selling. This institutional course correction acted as a powerful catalyst for price appreciation.

The most standout performer is Bajaj Consumer Care, which skyrocketed by nearly 265% in a single year. FIIs had systematically reduced their holding from 10.95% in June 2025 to 9.7% by December 2025. However, recognizing a potential error, they ramped up their stake to 16.59% in the March 2026 quarter, propelling the stock from ₹169.8 to ₹619.7.

Acutaas Chemicals also saw significant momentum, with FII shareholding rising from 16.94% to 19.48%, resulting in a 187% price surge (from ₹1,130.75 to ₹3,248.45).

Identifying the Multibagger Winners

Beyond the leaders, several other stocks capitalized on this institutional pivot. Even marginal shifts in FII ownership provided enough momentum to double stock prices:

  • SML Mahindra: Despite a massive initial sell-off where FII stakes dropped from 15.73% to just 0.61%, a subtle pivot in the March 2026 quarter coincided with a 124.75% return.
  • Dee Development Engineers: A directional shift in FII holding from 0.81% to 0.99% helped the stock climb 119% to reach ₹677.65.
  • United Foodbrands: Following a trough in September 2025, FII accumulation drove a 112% appreciation, taking the stock from ₹316.7 to ₹672.
  • RateGain Travel Technologies: After falling to 4.97%, FII ownership recovered to 5.35%, helping the stock jump 102% to ₹873.25.

Diverging Institutional Views on Future Strategy

As the market looks ahead, major brokerage houses and fund managers are divided on where the next leg of growth lies.

Nuvama’s strategy team favors demand-driven sectors, suggesting overweights in consumer, cement, chemicals, IT, private banks, and pharma, while remaining underweight on industrials and autos. Conversely, JM Financial is taking a defensive stance, cautioning against commodity price pressures and suggesting a tilt toward pharma, healthcare, and metals.

Tata Mutual Fund remains optimistic about large caps, anticipating that a potential US slowdown could drive emerging market flows back to India. Meanwhile, Bandhan AMC’s Manish Gunwani identifies small caps as the most attractive space for a three-to-five-year horizon, particularly in manufacturing and global capex plays like defence and energy infrastructure.

Key Takeaways

  • FII Pivots as Catalysts: Selective re-entry by foreign investors in the March quarter served as a major trigger for multibagger returns in specific mid-cap and consumer stocks.
  • Extreme Volatility in Holdings: Stocks like SML Mahindra showed that even after massive institutional exits, a minor directional shift can amplify upward momentum.
  • Diverse Market Outlooks: While some experts favor defensive sectors like pharma, others are eyeing small-cap manufacturing and global capex plays for long-term growth.